Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,815
Closed -$59K 3573
2025
Q3
$59K Buy
+16,815
New +$72.3K ﹤0.01% 2582
2025
Q2
Sell
-1,990
Closed -$7K 3081
2025
Q1
$7K Buy
+1,990
New +$9.11K ﹤0.01% 2383
2024
Q2
Sell
-3,720
Closed -$12K 2623
2024
Q1
$12K Buy
+3,720
New +$15.6K ﹤0.01% 2052
2023
Q4
Sell
-1,266
Closed -$2K 2683
2023
Q3
$2K Sell
1,266
-119
-9% -$274 ﹤0.01% 2239
2023
Q2
$3K Sell
1,385
-1,824
-57% -$5.26K ﹤0.01% 2262
2023
Q1
$9K Buy
3,209
+358
+13% +$1.25K ﹤0.01% 2262
2022
Q4
$6K Buy
2,851
+1,416
+99% +$4.71K ﹤0.01% 2260
2022
Q3
$5K Buy
+1,435
New +$6.96K ﹤0.01% 2590
2021
Q2
Sell
-1,011
Closed -$10K 3159
2021
Q1
$10K Buy
1,011
+10
+1% +$121 ﹤0.01% 2616
2020
Q4
$4K Buy
+1,001
New +$3.85K ﹤0.01% 1769

Other funds holding INUV

HRT Financial's INUV Position: Q4 2025 in Review

HRT Financial sold out of Inuvo (INUV) in Q4 2025, closing a stake of 16,815 shares — an estimated $59K sold.

HRT Financial first reported a position in INUV in Q4 2020 and held it in 10 quarters. The position peaked at $59K in Q3 2025. 29 funds tracked by Wall St. Rank hold INUV as of Q4 2025.

  • HRT Financial reported no remaining Inuvo position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 16,815 Inuvo shares in Q4 2025, an estimated $59K.
  • HRT Financial first reported a position in Inuvo in Q4 2020 and held it in 10 quarters.
  • HRT Financial's Inuvo position peaked at $59K in Q3 2025.
  • 29 funds tracked by Wall St. Rank held Inuvo as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.